This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Syneron Launches New Sublative ID™ Focal Tip To Reduce Fine Wrinkles In Hard To Reach Areas Around The Eyes And Mouth

IRVINE, California, December 11, 2012 /PRNewswire/ --

Syneron Medical Ltd. (NASDAQ: ELOS),, the global leader in medical aesthetic products and technologies, announced the launch of a new Sublative iD™ Focal Tip for challenging treatment areas such as the nasolabial fold ("smile lines") and periorbital rim ("around the eyes").  The new Sublative iD Focal Tip will be available for use on all of Syneron's proprietary Sublative™ compatible systems, which includes elōs Plus™, eTwo™ and eMatrix™.

"We are pleased to provide our customers with the new Sublative iD Focal Tip for use with Syneron's unique Sublative treatment systems. This offering was developed to meet the needs of our customers and expand their treatment capabilities to better serve their patients," said Louis P. Scafuri, Chief Executive Officer at Syneron. " This new tip broadens the applications of our sublative hand piece which, in turn, expands our customers ROI and profitability from the eMatrix, eTwo and elōs Plus devices."

The new Sublative iD Focal Tip features an array of 44 pins on a re-connectable compact tip design that is compatible with any Sublative applicator.  "Many of my patients, particularly my younger patients, wish to consider non-surgical as well as surgical options for improvement in the early signs of aging around their eyes," said Alan Gold, M.D., F.A.C.S board certified plastic surgeon in Great Neck, New York. "Using energy-based devices to treat around the periorbital area has previously been technically challenging primarily due to the size of the available applicators. However, the new Sublative iD Focal Tip has been intelligently designed for greater maneuverability and better fit in the smaller, harder to contour areas making it an attractive option which has allowed me to expand the application of Sublative treatment in my practice."  

For more information about the new Sublative iD Focal Tip or any of Syneron's broad product offering, visit

About Syneron Medical Ltd.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,749.20 -27.23 -0.16%
S&P 500 1,975.78 -11.27 -0.57%
NASDAQ 4,725.1930 -56.0710 -1.17%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs